Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Edition
European
US
Oncology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Helicobacter Pylori Treatment Could Minimise Gastric Cancer Risk
1
Mins
July 2024
Researchers have unveiled that Helicobacter pylori treatment may be beneficial for individuals with a high genetic risk to gastric cancer.
Read more
3
Mins
5th June 2017
F-Star Expands Its Relationship with Merck Through a New Strategic Collaboration to Develop Bispecific Antibodies in Immuno-Oncology
Cambridge, UK, June 04, 2017 – F-star, a biopharmaceutical company developing novel bispecific antibodies, announces today a new partnership with Merck…
5
Mins
5th June 2017
Darzalex®▼ (daratumumab) Combination Therapy Improved Clinical Outcomes Regardless of Cytogenetic Risk for Previously-Treated Patients with Multiple Myeloma
Beerse, Belgium, June 4, 2017 – Janssen-Cilag International NV (“Janssen”) today announced new data from updated analyses of the pivotal Phase 3 CASTOR…
2
Mins
24th May 2017
Immunoscore®, Immunosign® and Halioseek™ at ASCO 2017
Marseille, France, May 23, 2017 – HalioDx SAS, an immuno-oncology diagnostic company, announced its participation at the 2017 American Society of…
3
Mins
16th May 2017
Philips Showcases New Integrated Image-Guided Therapy Solutions at 2017 EuroPCR to Transform Cardiac Care and Help Improve Patient Care
Amsterdam, May 16, 2017 – Royal Philips (NYSE: PHG, AEX: PHIA) will showcase its market-leading image guided therapy solutions at EuroPCR 2017…
3
Mins
11th May 2017
University Research Opens Door to U.S. Market for UK Chemotherapy Scalp Cooling Firm
Huddersfield, UK, 10 May, 2017 – A pioneering UK company that produces technology designed to reduce hair loss during cancer treatment has been given…
2
Mins
9th May 2017
Introducing EMJ Urology 5.1
United Kingdom, May 09, 2017: Welcome to the newest edition of our EMJ Urology eJournal, packed with the latest urological developments. This issue is…
1
Mins
2nd May 2017
New Hope in Fight Against Pancreatic Cancer
MIR506, a small microRNA molecule, could be the key to new treatments to suppress deadly and aggressive pancreatic cancer, a new study has found. Through…
1
Mins
26th April 2017
European Society for Medical Oncology (ESMO): Annual Flu Jab May Pose Greater Risk for Lung Cancer Patients Under Immunotherapy
Geneva, Switzerland, 26 April, 2017 – Lung cancer patients treated with immunotherapy may be at increased risk of adverse events after receiving the…
Loading posts...
« Previous
1
…
18
19
20
21
22
…
32
Next »